Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 49.29

-2.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: biowa who wrote (929)	4/13/2000 8:59:00 AM
From: Biomaven	Read Replies (1) of 52153

biowa, Maybe the bears are particularly mad at biotech because nobody is sequencing the bear genome. <g> Obviously it's hard to disentangle the biotech slide from the Nasdaq/dot.com weakness. However, looking at just the biotech news there has been reason for weakness. BGEN mediocre earnings, AMGN dispute with TKTX, punctured hype by CRA, VPHM crash (ouch - I still held a few). Things are looking up today, though: Nice earnings from Genenetech, and a positive review of the SEPR/LLY Prozac deal. (And maybe the tech stocks will get helped by AMD). I'm looking to buy back some of the MLNM I sold at higher prices, and selectively nibbling on a few other issues (like VPHM). Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next